Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 12:38PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 32.45B |
| Enterprise Value | 38.32B |
| Trailing P/E | 27.86 |
| Forward P/E | 14.37 |
| PEG Ratio (5 yr expected) | 6.24 |
| Price/Sales (ttm) | 3.36 |
| Price/Book (mrq) | 2.13 |
| Enterprise Value/Revenue | 3.97 |
| Enterprise Value/EBITDA | 18.19 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | -0.01 |
| 52-Week Change 3 | -28.05% |
| S&P500 52-Week Change 3 | 26.43% |
| 52 Week High 3 | 319.76 |
| 52 Week Low 3 | 189.44 |
| 50-Day Moving Average 3 | 211.96 |
| 200-Day Moving Average 3 | 240.68 |
Share Statistics
| Avg Vol (3 month) 3 | 1.31M |
| Avg Vol (10 day) 3 | 1.2M |
| Shares Outstanding 5 | 145.6M |
| Implied Shares Outstanding 6 | 145.6M |
| Float 8 | 145.05M |
| % Held by Insiders 1 | 0.16% |
| % Held by Institutions 1 | 93.42% |
| Shares Short (Apr 15, 2024) 4 | 3.26M |
| Short Ratio (Apr 15, 2024) 4 | 2.77 |
| Short % of Float (Apr 15, 2024) 4 | 2.55% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 2.25% |
| Shares Short (prior month Mar 15, 2024) 4 | 2.66M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 3:1 |
| Last Split Date 3 | Jan 18, 2001 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 12.07% |
| Operating Margin (ttm) | 27.28% |
Management Effectiveness
| Return on Assets (ttm) | 4.86% |
| Return on Equity (ttm) | 8.05% |
Income Statement
| Revenue (ttm) | 9.66B |
| Revenue Per Share (ttm) | 66.69 |
| Quarterly Revenue Growth (yoy) | -7.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | 2.52B |
| Net Income Avi to Common (ttm) | 1.17B |
| Diluted EPS (ttm) | 8.00 |
| Quarterly Earnings Growth (yoy) | 1.40% |
Balance Sheet
| Total Cash (mrq) | 1.07B |
| Total Cash Per Share (mrq) | 7.38 |
| Total Debt (mrq) | 6.95B |
| Total Debt/Equity (mrq) | 45.66% |
| Current Ratio (mrq) | 2.10 |
| Book Value Per Share (mrq) | 104.49 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.65B |
| Levered Free Cash Flow (ttm) | 899.92M |
© 2024 Yahoo. All rights reserved.